Peripheral administration of vasopressin for catecholamine-resistant hypotension complicated by skin necrosis [3]

Critical Care Medicine

Volumn 34, Issue 3, 2006, Pages 935-

  Bunker, Nick ^a   Higgins, David ^a  

^a Southend NHS Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; DOBUTAMINE; HYPERTENSIVE FACTOR; NORADRENALIN; VASOPRESSIN;

ADULT; BLISTER; CANNULA; CASE REPORT; CENTRAL VENOUS CATHETERIZATION; DRUG MEGADOSE; ESOPHAGUS VARICES; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPOTENSION; INFUSION; LETTER; PERIPHERAL VEIN; PRIORITY JOURNAL; SEPTIC SHOCK; SKIN NECROSIS;

CATHETERIZATION, PERIPHERAL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; NECROSIS; SHOCK, SEPTIC; SKIN DISEASES; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 33644591291     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000202202.85087.37     Document Type: Letter

References (4)

1. Dellinger RP, Carlet JM, Masur H, et al: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30:536-555
2. Holmes CL, Walley KR, Chittock DR, et al: The effects of vasopressin on haemodynamics and renal function in severe septic shock: A case series. Intensive Care Med 2001; 27:1416-1421
3. Morgan GR, Wormser GP, Gottfried EB: Infected gangrene. A serious complication of peripheral vasopressin administration. Am J Gastroenterol 1980; 73:426-429
4. Kahn JM, Kress JP, Hall JB: Skin necrosis after extravasation of low-dose vasopressin administered for septic shock. Crit Care Med 2002; 30:1899-1901